New IMRT techniques could be tissue-sparing and promote dosage conformity in breast cancer
New IMRT techniques could be tissue-sparing and promote dosage conformity in breast cancer
Tamoxifen lowered breast cancer rates among high-risk women
Fulvestrant versus anastrozole in patients with advanced breast cancer
Reducing fat intake reduces death rates in some breast cancer patients
Recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer
Breast cancer in men and women has different biological characteristics and outcomes
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer
Comment: Impact of combined bevacizumab and presurgery chemo varies by subtype
Adding ultrasound to routine mammography improves cancer detection in dense breasts
High tumour immune cell levels may help screen HER2-positive breast cancer patients for chemo
CLL at ASH 2014: Expert discussion
BOLERO-1 reports HER2-positive breast cancer latest PFS data